What does BIOPHARM do?

BIOPHARM is a pharmacy in Kortenberg. Public Limited, started on 10 October 1989, 8 establishments.

What is the address of BIOPHARM?

The registered office of BIOPHARM is located at Stationstraat 8, 3070 Kortenberg.

Is BIOPHARM still active?

Yes. According to the CBE (30 October 2026) BIOPHARM is active, legal situation “Normale toestand”, started on 10 October 1989.

Is BIOPHARM registered on Peppol?

Yes, BIOPHARM is registered on the Peppol network with ID 0208:0438547292.

What is the enterprise number of BIOPHARM?

The enterprise number of BIOPHARM is BE0438547292.

When was BIOPHARM founded?

BIOPHARM was founded on 10 October 1989.

Is BIOPHARM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 October 1989; 5 annual accounts filed, latest fiscal year 2025; 8 establishments in the CBE.

How much profit did BIOPHARM make in 2025?

BIOPHARM recorded a loss after taxes of € 43,547 in financial year 2025.

What is the revenue of BIOPHARM?

In its most recent annual accounts (2025), BIOPHARM reported revenue of € 10,327,378.

Does BIOPHARM have a website?

Yes, BIOPHARM has a website at biopharm.be.

BIOPHARM (Public Limited) - Kortenberg - BE0438547292

Dossier BIOPHARM, printed on 30 October 2026 from databakkes.be/en/0438547292/biopharm. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.

Financials

Financial year 2025

BIOPHARM from Kortenberg, company number BE0438547292, closed financial year 2025 with a result of € -43,547 after tax. For that financial year BIOPHARM recorded revenue of € 10.3 million and equity of € 5.4 million. Compared with financial year 2024, the result moved from € -16,199 to € -43,547. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 30, 2026.

What it is worth Healthy

€ 5.4 million

▼ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -43,547

▼ 169 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 8,070

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 1.9 million.

People and assets in 2025

Wage cost

€ 1.2 million

▲ 7% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 106,990

▲ 46% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 3.5 million

▼ 1% vs 2024

€ 475,253 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 1.4 million

▲ 16% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 110,730

▲ 7% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 8,039,187 Revenue 2022: € 8,039,187 First fiscal year in the series	€ 8,762,469 Revenue 2023: € 8,762,469 ▲ 9% vs 2022 (€ 8,039,187) Favourable step	€ 9,173,357 Revenue 2024: € 9,173,357 ▲ 5% vs 2023 (€ 8,762,469) Favourable step	€ 10,327,378 Revenue 2025: € 10,327,378 ▲ 13% vs 2024 (€ 9,173,357) Favourable step	▲ 13%
Gross margin	€ 1,446,306 Gross margin 2022: € 1,446,306 First fiscal year in the series	€ 1,595,415 Gross margin 2023: € 1,595,415 ▲ 10% vs 2022 (€ 1,446,306) Favourable step	€ 1,761,043 Gross margin 2024: € 1,761,043 ▲ 10% vs 2023 (€ 1,595,415) Favourable step	€ 1,913,000 Gross margin 2025: € 1,913,000 ▲ 9% vs 2024 (€ 1,761,043) Favourable step	▲ 9%
Profit after taxes	€ -70,526 Profit after taxes 2022: € -70,526 First fiscal year in the series	€ -73,906 Profit after taxes 2023: € -73,906 ▼ € 3,380 vs 2022 (€ -70,526) Unfavourable step	€ -16,199 Profit after taxes 2024: € -16,199 ▲ € 57,707 vs 2023 (€ -73,906) Favourable step	€ -43,547 Profit after taxes 2025: € -43,547 ▼ € 27,348 vs 2024 (€ -16,199) Unfavourable step	▼ € 27,348
Equity	€ 5,503,487 Equity 2022: € 5,503,487 First fiscal year in the series	€ 5,429,581 Equity 2023: € 5,429,581 ▼ 1% vs 2022 (€ 5,503,487) Unfavourable step	€ 5,413,383 Equity 2024: € 5,413,383 Unchanged (€ 5,429,581) Unfavourable step	€ 5,369,834 Equity 2025: € 5,369,834 ▼ 1% vs 2024 (€ 5,413,383) Unfavourable step	▼ 1%
Total debts	€ 5,590,092 Total debts 2022: € 5,590,092 First fiscal year in the series	€ 5,608,813 Total debts 2023: € 5,608,813 Unchanged (€ 5,590,092) Unfavourable step	€ 5,788,747 Total debts 2024: € 5,788,747 ▲ 3% vs 2023 (€ 5,608,813) Unfavourable step	€ 6,077,733 Total debts 2025: € 6,077,733 ▲ 5% vs 2024 (€ 5,788,747) Unfavourable step	▲ 5%
Cash	€ 3,226 Cash 2022: € 3,226 First fiscal year in the series	-	-	€ 8,070 Cash 2025: € 8,070 First fiscal year in the series
Land & buildings	€ 6,612,205 Land & buildings 2022: € 6,612,205 First fiscal year in the series	€ 5,955,113 Land & buildings 2023: € 5,955,113 ▼ 10% vs 2022 (€ 6,612,205) Unchanged	€ 5,688,894 Land & buildings 2024: € 5,688,894 ▼ 4% vs 2023 (€ 5,955,113) Unchanged	€ 5,436,029 Land & buildings 2025: € 5,436,029 ▼ 4% vs 2024 (€ 5,688,894) Unchanged	▼ 4%
Retained profit	€ 2,050,157 Retained profit 2022: € 2,050,157 First fiscal year in the series	€ 1,976,251 Retained profit 2023: € 1,976,251 ▼ 4% vs 2022 (€ 2,050,157) Unfavourable step	€ 1,960,053 Retained profit 2024: € 1,960,053 ▼ 1% vs 2023 (€ 1,976,251) Unfavourable step	€ 1,916,504 Retained profit 2025: € 1,916,504 ▼ 2% vs 2024 (€ 1,960,053) Unfavourable step	▼ 2%
Bank debt	€ 3,304,105 Bank debt 2022: € 3,304,105 First fiscal year in the series	€ 3,370,948 Bank debt 2023: € 3,370,948 ▲ 2% vs 2022 (€ 3,304,105) Unfavourable step	€ 3,504,914 Bank debt 2024: € 3,504,914 ▲ 4% vs 2023 (€ 3,370,948) Unfavourable step	€ 3,483,229 Bank debt 2025: € 3,483,229 ▼ 1% vs 2024 (€ 3,504,914) Favourable step	▼ 1%
Balance sheet total	€ 11,765,563 Balance sheet total 2022: € 11,765,563 First fiscal year in the series	€ 11,672,146 Balance sheet total 2023: € 11,672,146 ▼ 1% vs 2022 (€ 11,765,563) Unchanged	€ 11,797,650 Balance sheet total 2024: € 11,797,650 ▲ 1% vs 2023 (€ 11,672,146) Unchanged	€ 12,004,854 Balance sheet total 2025: € 12,004,854 ▲ 2% vs 2024 (€ 11,797,650) Unchanged	▲ 2%

Key figures of BIOPHARM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to BIOPHARM?

What happened at BIOPHARM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 30, 2026 New annual accounts for financial year 2025: loss of € 43,547. Source: NBB ↗
Jan 1, 2019 New establishment in Tienen. KBO
Nov 22, 2012 New establishment in Lubbeek. KBO
Apr 1, 2009 New establishment in Lille. KBO
Oct 1, 2008 New establishment in Hoogstraten. KBO
Oct 29, 1999 New establishment in Huldenberg. KBO
Jun 26, 1998 New establishment in Merksplas. KBO
Oct 15, 1992 New establishment in Tienen. KBO

In short

From € 70,526 loss in 2022 to € 43,547 loss in 2025.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Stationstraat 8

3070 Kortenberg

2.045.419.204

Peperstraat 19

3300 Tienen

Active since 15 October 1992

2.182.947.485

Molenzijde 3 box 2330

2330 Merksplas

Active since 26 June 1998

2.182.947.881

Wolfshaegen 74 box A

3040 Huldenberg

Active since 29 October 1999

2.182.948.178

Dorp 16

2275 Lille

Active since 1 April 2009

2.182.949.861

Meerledorp 46

2328 Hoogstraten

Active since 1 October 2008

2.226.333.310

Staatsbaan(LUB) 85

3210 Lubbeek

Active since 22 November 2012

2.285.113.627

Vierde Lansierslaan 6

3300 Tienen

Active since 1 January 2019

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

SoBiVet

€ 15,430 revenue · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS biopharm.be

Technologies

ASP.NETGoogle AnalyticsGoogle FontsLeafletNginxPHPjQueryunpkg

Hosting & Email

Email provider

Microsoft 365

Hosting

COMBELL-AS, BE

Website info

HTTPS Ja

Indexable pages 17

Languages NL

Features

Blog Contact page

Security

✓ HTTPS

✓ SPF

✓ DMARC

Network

✓ IPv6

Details

Company number

0438.547.292

VAT number

BE 0438.547.292

Registered office

Stationstraat 8, 3070 Kortenberg

Names & denominations

BIOPHARM

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

10 October 1989

Peppol

Active · Active since 19 Dec 2025

Contact

biopharm.be [email protected] 016622141

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗